MAS825
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MAS825, covering 2022-04-20 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease [Phase 2]